The health department in Pune district has administered the Bacillus Calmette-Guerin (BCG) vaccine to more than 4,500 adults. This is part of a larger statewide study aimed at assessing the vaccine's effectiveness in preventing Mycobacterium Tuberculosis infection among adults. Tuberculosis, a serious respiratory disease caused by the Mycobacterium tuberculosis bacteria, can lead to significant morbidity and mortality. The BCG vaccine, traditionally given to newborns to protect against tuberculosis, is now being explored for its potential to prevent the disease in adults, particularly those at high risk. To determine the efficacy of the BCG vaccine in preventing tuberculosis among adults, the study involves two groups of participants: a vaccinated group and an unvaccinated group. Both groups will be closely monitored for the next three years to compare the rates of tuberculosis infection between the two. The study will also track other outcomes, such as the severity of illness, treatment response, and mortality rates. The BCG vaccination will be conducted over a three-month period, followed by a mop-up round to cover the remaining eligible population. For the next three years, both vaccinated and unvaccinated groups will be closely monitored to evaluate the vaccine's effectiveness, potential complications, response to treatment, and time to cure. Regular follow-up visits will be conducted to collect data on health outcomes and assess the impact of the vaccine. Tuberculosis PreventionThe BCG vaccine, traditionally administered to newborns, is being explored for its potential to reduce tuberculosis infection among adults and high-risk individuals. Similar studies have been conducted in other states, such as Goa and Himachal Pradesh, to investigate the vaccine's efficacy in different populations. If found to be effective, the BCG vaccine could provide a valuable tool for preventing tuberculosis in adults, particularly in regions with high rates of the disease. Early Signs of TBAccording to Centre of Disease Control (CDC), if you have active TB in your lungs, you might have a bad cough that lasts more than 3 weeks, chest pain, or coughing up blood. You might also feel weak, lose weight, have no appetite, get chills, have a fever, or sweat a lot at night. If TB is in other parts of your body, the symptoms depend on where it is. For example, TB in your lymph nodes might cause a swollen lump under your skin. TB in your kidneys could make your urine look bloody. TB in your brain might cause headaches or confusion. TB in your spine could cause back pain. TB in your larynx could make your voice hoarse. Inactive TB means you don't have any symptoms, but it can turn into active TB and make you sick if you don't get treatment.